Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy
-
Published:2019-12
Issue:1
Volume:2
Page:
-
ISSN:2399-3642
-
Container-title:Communications Biology
-
language:en
-
Short-container-title:Commun Biol
Author:
Hosoda Yoshikatsu, Miyake Masahiro, Schellevis Rosa L., Boon Camiel J. F., Hoyng Carel B., Miki Akiko, Meguro Akira, Sakurada Yoichi, Yoneyama Seigo, Takasago Yukari, Hata Masayuki, Muraoka Yuki, Nakanishi Hideo, Oishi AkioORCID, Ooto Sotaro, Tamura HiroshiORCID, Uji Akihito, Miyata ManabuORCID, Takahashi Ayako, Ueda-Arakawa Naoko, Tajima AtsushiORCID, Sato TakehiroORCID, Mizuki Nobuhisa, Shiragami ChiekoORCID, Iida Tomohiro, Khor Chiea ChuenORCID, Wong Tien Yin, Yamada Ryo, Honda Shigeru, de Jong Eiko K.ORCID, Hollander Anneke I. denORCID, Matsuda Fumihiko, Yamashiro KenjiORCID, Tsujikawa Akitaka
Abstract
AbstractThe recently emerged pachychoroid concept has changed the understanding of age-related macular degeneration (AMD), which is a major cause of blindness; recent studies attributed AMD in part to pachychoroid disease central serous chorioretinopathy (CSC), suggesting the importance of elucidating the CSC pathogenesis. Our large genome-wide association study followed by validation studies in three independent Japanese and European cohorts, consisting of 1546 CSC samples and 13,029 controls, identified two novel CSC susceptibility loci: TNFRSF10A-LOC389641 and near GATA5 (rs13278062, odds ratio = 1.35, P = 1.26 × 10−13; rs6061548, odds ratio = 1.63, P = 5.36 × 10−15). A T allele at TNFRSF10A-LOC389641 rs13278062, a risk allele for CSC, is known to be a risk allele for AMD. This study not only identified new susceptibility genes for CSC, but also improves the understanding of the pathogenesis of AMD.
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference58 articles.
1. Gemenetzi, M., De Salvo, G. & Lotery, A. J. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye 24, 1743–1756 (2010). 2. Kitzmann, A. S., Pulido, J. S., Diehl, N. N., Hodge, D. O. & Burke, J. P. The incidence of central serous chorioretinopathy in Olmsted county, Minnesota, 1980-2002. Ophthalmology 115, 169–173 (2008). 3. Nicholson, B., Noble, J., Forooghian, F. & Meyerle, C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv. Ophthalmol. 58, 103–126 (2013). 4. Bujarborua, D. Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmol. Scand. 79, 417–421 (2001). 5. Breukink, M. B. et al. Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin. Ophthalmol. 11, 39–46 (2016).
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|